Skip to main content

Vor Biopharma Inc.

VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817229

In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Vor Biopharma Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of VOR: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3537+2
SharesConverted for a 1-for-20 split2.85M3.76M+909.9K (+31.9%)
Value$91.9M$183.4M+$91.5M (+99.6%)

New holders (12)

Institutions that held Vor Biopharma Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to VOR in Q3 2025
InstitutionSharesValue% of portfolio
VR Adviser, LLC499,966$24.4M1.37%
FCPM III Services B.V.379,640$18.5M3.70%
Ariose Capital Management Ltd110,173$5.37M1.80%
Tang Capital Management LLC50,000$2.44M0.09%
Woodline Partners LP27,363$1.33M0.01%
Millennium Management LLC24,764$1.21M0.00%
Polymer Capital Management (HK) LTD21,248$1.04M0.14%
Bridgeway Capital Management, LLC6,250$304.5K0.01%
Citadel Advisors LLC5,686$277.0K0.00%
Squarepoint Ops LLC4,729$230.4K0.00%
Caitong International Asset Management Co., Ltd110$5.36K0.00%
Wells Fargo & Company1$490.00%

Sold out (10)

Institutions that held Vor Biopharma Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of VOR in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
5AM Venture Management, LLC6,361,723$10.3M
HRT Financial LP474,575$768.0K
Two Sigma Investments, LP169,636$274.8K
Two Sigma Securities, LLC94,394$152.9K
Citigroup Inc87,485$141.7K
Northern Trust Corp72,417$117.3K
DGS Capital Management, LLC55,300$89.6K
XTX Topco Ltd40,943$66.3K
Chicago Partners Investment Group LLC10,887$22.8K
NBC Securities, Inc.1,000$1.00K